GR930300027T1 - - Google Patents

Info

Publication number
GR930300027T1
GR930300027T1 GR930300027T GR930300027T GR930300027T1 GR 930300027 T1 GR930300027 T1 GR 930300027T1 GR 930300027 T GR930300027 T GR 930300027T GR 930300027 T GR930300027 T GR 930300027T GR 930300027 T1 GR930300027 T1 GR 930300027T1
Authority
GR
Greece
Application number
GR930300027T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR930300027T1 publication Critical patent/GR930300027T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
GR930300027T 1987-02-27 1993-05-24 GR930300027T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1991587A 1987-02-27 1987-02-27

Publications (1)

Publication Number Publication Date
GR930300027T1 true GR930300027T1 (el) 1993-05-24

Family

ID=21795732

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930300027T GR930300027T1 (el) 1987-02-27 1993-05-24

Country Status (26)

Country Link
EP (1) EP0280571B1 (el)
JP (1) JPH082793B2 (el)
KR (1) KR960005140B1 (el)
CN (1) CN1023765C (el)
AR (1) AR243376A1 (el)
AT (1) ATE92309T1 (el)
AU (1) AU604849B2 (el)
CA (1) CA1316110C (el)
CY (1) CY1741A (el)
DE (2) DE3882739T2 (el)
DK (1) DK175620B1 (el)
EG (1) EG18523A (el)
ES (1) ES2044825T3 (el)
GR (1) GR930300027T1 (el)
HK (1) HK125793A (el)
HU (1) HU202747B (el)
IE (1) IE61419B1 (el)
IL (1) IL85538A (el)
LV (1) LV10184B (el)
MX (1) MX10558A (el)
NZ (1) NZ223619A (el)
PH (1) PH24358A (el)
PT (1) PT86831B (el)
RU (1) RU1831337C (el)
UA (1) UA18251A (el)
ZA (1) ZA881301B (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
RU2113221C1 (ru) * 1990-05-04 1998-06-20 Ииссум Рисерч Дивелопмент Компани оф дзе Хебрю Юниверсити оф Иеруcалим Фармацевтическая форма для введения лекарственного средства в ободочную кишку, способ введения лекарственного препарата и способ получения матриц для такой формы
FR2667242B1 (fr) * 1990-09-28 1994-11-25 Rhone Poulenc Sante Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri.
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
JP2864737B2 (ja) * 1993-10-22 1999-03-08 株式会社ツムラ 徐放性製剤用基剤並びに徐放性製剤及び該製剤の製造方法
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
BR9709452B1 (pt) * 1996-05-13 2008-11-18 sistema de liberaÇço bucal na forma de uma pastilha degastÁvel.
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
JP2002505290A (ja) * 1998-03-03 2002-02-19 ダエウン ファーマシューティカル カンパニー リミテッド 水分吸収に対して安定であるセフロキシムアクセチルを含む医薬組成物
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
EP1970052A2 (en) * 1999-02-09 2008-09-17 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability
KR100647901B1 (ko) * 1999-07-09 2006-11-17 보령제약 주식회사 세파클러-함유 서방성 약제조성물 및 그의 제조방법
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
WO2001047403A1 (en) 1999-12-28 2001-07-05 Kimberly-Clark Worldwide, Inc. Use-dependent indicator system for absorbent articles
MXPA02006424A (es) 1999-12-28 2002-11-29 Kimberly Clark Co Pano limpiador antimicrobial de liberacion controlada para superficies duras.
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
WO2002036126A1 (en) * 2000-10-30 2002-05-10 Lupin Limited Rapidly disintegrating sustained release cefuroxime axetil composition
CA2514879C (en) * 2003-01-03 2014-09-16 Shire Laboratories Inc. Two or more enteric materials to regulate drug release
DE102005019458A1 (de) 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
EP1837020A1 (en) * 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
CA2597740C (en) 2006-04-26 2012-10-16 Supernus Pharmaceuticals, Inc. Modified-release preparations containing oxcarbazepine and derivatives thereof
EP2090298A4 (en) * 2006-11-13 2014-02-26 Kyorin Seiyaku Kk METHOD FOR PRODUCING A TABLET WITH DELAYED RELEASE
KR20120003906A (ko) 2009-03-27 2012-01-11 교린 세이야꾸 가부시키 가이샤 염기성 첨가제를 함유하는 매트릭스형 서방성 제제
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
WO2015190456A1 (ja) * 2014-06-10 2015-12-17 ライオン株式会社 清酒酵母を含有する錠剤
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151913B (el) * 1980-01-11 1983-09-03 Boots Co Ltd
JPS6024765B2 (ja) * 1981-11-27 1985-06-14 辰巳化学株式会社 セフアレキシンの持続性製剤の製造方法
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法

Also Published As

Publication number Publication date
RU1831337C (ru) 1993-07-30
DE3882739D1 (de) 1993-09-16
CA1316110C (en) 1993-04-13
IE880545L (en) 1988-08-27
IE61419B1 (en) 1994-11-02
NZ223619A (en) 1990-10-26
AU604849B2 (en) 1991-01-03
IL85538A0 (en) 1988-08-31
ES2044825T1 (es) 1994-01-16
UA18251A (uk) 1997-12-25
EP0280571B1 (en) 1993-08-04
HUT46531A (en) 1988-11-28
ZA881301B (en) 1989-10-25
EP0280571A3 (en) 1989-01-04
PT86831A (pt) 1988-03-01
PH24358A (en) 1990-06-13
CY1741A (en) 1995-02-17
DK98088D0 (da) 1988-02-25
CN88101062A (zh) 1988-09-07
AU1219388A (en) 1988-09-01
HU202747B (en) 1991-04-29
CN1023765C (zh) 1994-02-16
ATE92309T1 (de) 1993-08-15
KR880009639A (ko) 1988-10-04
EP0280571A2 (en) 1988-08-31
DK98088A (da) 1988-08-28
HK125793A (en) 1993-11-19
DE3882739T2 (de) 1994-02-17
KR960005140B1 (ko) 1996-04-22
PT86831B (pt) 1992-05-29
DE280571T1 (de) 1993-08-12
JPS63227519A (ja) 1988-09-21
IL85538A (en) 1991-09-16
DK175620B1 (da) 2004-12-27
EG18523A (en) 1993-04-30
MX10558A (es) 1993-11-01
ES2044825T3 (es) 1994-11-16
AR243376A1 (es) 1993-08-31
JPH082793B2 (ja) 1996-01-17
LV10184A (lv) 1994-10-20
LV10184B (en) 1995-04-20

Similar Documents

Publication Publication Date Title
DE3790884T1 (el)
GR930300027T1 (el)
DE8702660U1 (el)
DE3879938D1 (el)
DE8702244U1 (el)
DE8702296U1 (el)
DE8700437U1 (el)
DE8702221U1 (el)
DE8700905U1 (el)
DE8702433U1 (el)
DE8702324U1 (el)
DE8701441U1 (el)
DE8701256U1 (el)
DE8703284U1 (el)
DE8702427U1 (el)
DE8702077U1 (el)
DE8702377U1 (el)
DE8700194U1 (el)
DE8702583U1 (el)
DE8702589U1 (el)
DE8700104U1 (el)
DE8702220U1 (el)
DE8713587U1 (el)
DE8702458U1 (el)
DE8700862U1 (el)